Appeal No. 95-4791
Application 08/034,849
“the various subsidiary forms of the HIV virus” (Specification
(Spec.), p. 1, l. 9-10). Therefore, appellant’s claims are
limited to a method of treating the various subsidiary forms
of the HIV virus by parenterally administering amounts of the
chemically-stabilized chlorite matrix effective to inhibit one
or more of the various forms of HIV virus to a subject
infected by one or more of the various forms of HIV virus. It
is to be understood that opportunistic infections associated
with infections by one or more of the various forms of the HIV
virus simultaneously may be treated by the method claimed.
However, the claims require the step of administering amounts
of a chemically-stabilized chlorite matrix to a subject
infected by one or more of the various forms of
the HIV virus in amounts effective to inhibit the HIV viral
infection.
2. Prior art teaching
A. Sanosa, The Merck Index, and Acknowledgments
The examiner finds that Sanosa and The Merck Index teach
stabilized chlorite solutions of the type utilized in
appellant’s claimed process for use as topical, surgical,
and/or wound disinfectants and antiseptics (Ans., pp. 3-4).
We need not dwell on the question whether the examiner erred
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007